Dr. Sébastien Hazard
Equibles does not estimate personal net worth.
About Dr. Sébastien Hazard
Imunon, Inc. reported in an 8-K filed December 11, 2023 that Dr. Sébastien Hazard was appointed Executive Vice President and Chief Medical Officer, effective December 11, 2023. Imunon, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Imunon, Inc. includes Corinne Le Goff (CEO and Board Member), Michael Tardugno (CEO and Chairman), Stacy Lindborg (CEO and Board Member) and 7 others.
“On December 7, 2023, Imunon, Inc. (the "Company") appointed Dr. Sébastien Hazard to the positions of Executive Vice President and Chief Medical Officer of the Company, effective as of December 11, 2023.”
Affiliation history
-
Imunon, Inc. (IMNN)
SEC 8-K
Current2023-12-11–present
Company network
Leadership on record at Imunon, Inc.
- Corinne Le Goff CEO, Board Member
- Michael Tardugno CEO, Chairman
- Stacy Lindborg CEO, Board Member
- Stacy R. Lindborg CEO, Board Member
- Stacy R. Lindborg, Ph.D. CEO
- Michael H. Tardugno Chairman
- David Gaiero CFO
- Josh Blacher CFO
- Kimberly Graper CFO
- Susan Eylward General Counsel